http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101716178-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9de52bba13e16028dffa8775e3f3f28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_894d61cb032f8c06f5c6e0338af8797b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1598b13bc8795b9bfa581b9c7ec4ba75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027b973bffca62a7e3934eed09c431e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e4a23ca179cbd5bcb0f800d59908fa |
| publicationDate | 2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101716178-B |
| titleOfInvention | Antitumor medicament |
| abstract | The invention discloses an antitumor medicament in the technical field of medicine chemical industry, which refers to 6-substituted-5, 6-dihydropyrrol [3, 4-d] pyridine-7-ketone (IV), having the following structural general formulas. The medicament is a compound with higher protein kinase inhibiting activity, has a simple preparation method and convenient raw material sources, is easy to realize industrialization and can satisfy the requirement for preparing the medicament for clinically treating cancers. |
| priorityDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467714617 |
Total number of triples: 16.